Peru opened 75% more cases for product biopiracy in the world than in 2019

Published 2021년 2월 24일

Tridge summary

In 2020, the National Commission against Biopiracy (CNB) in Peru identified a 75% increase in potential biopiracy cases, with 42 patent processes under investigation from the previous year. These cases involve the unauthorized use of Peruvian biological resources such as maca, blood of grade, sacha inchi, and more, from patent offices around the world, including China, USA, Japan, and Brazil. The Peruvian Foreign Ministry and Indecopi have opposed 34 of these cases to prevent improper patenting. The CNB monitors 268 Peruvian biological resources to ensure no unauthorized patent applications are made, adhering to the Convention on Biological Diversity and national regulations.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The National Commission against Biopiracy (CNB), chaired by the National Institute for the Defense of Competition and the Protection of Intellectual Property (Indecopi), identified a total of 42 patent processes around the world in 2020, 75% more than what was registered in 2019. These cases of possible biopiracy were identified in patent offices located in China, United States of America, Japan, Brazil, Australia, France, Uruguay, Canada, Argentina, Mexico, Chile, Philippines, Taiwan, among other. The biological resources of Peruvian origin affected are maca, blood of grade, sacha inchi, ungurahui, purple corn, camu camu, tara, pasuchaca, yacón, aguaje, among others. The Peruvian Foreign Ministry and Indecopi have filed oppositions to 34 of these cases, in order to prevent them from becoming improperly patents in the future. The remaining oppositions are expected to be submitted before April. At the moment, it is known that the CNB published twelve bulletins in 2020, prepared ...

Source: AgroForumPeru